Published • loading... • Updated
FDA Begins Real-Time AI Trial Pilot with AstraZeneca, Amgen
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
FDA Begins Real-Time AI Trial Pilot with AstraZeneca, Amgen
The FDA began accepting live AI and cloud data feeds from AstraZeneca's TRAVERSE and Amgen's STREAM-SCLC oncology trials, targeting 20-40% faster trials. The post FDA Begins Real-Time AI Trial Pilot with AstraZeneca, Amgen appeared first on WinBuzzer.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
